Genomic analyses in human cancers further showed that TP53 mutations belong to the most common alterations across all cancer types, with mCRPC harboring alterations in up to 50% of samples tested and contributing to chromosomal instability, oncogene amplification, and poor prognosis in patients with mutated p53 profiles [7]. The gene discussed is TP53; the disease is cancer.